Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

305
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
305
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

73
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
73
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

406
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
406
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

685
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
685
Drug Therapy01:28

Drug Therapy

346
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
346

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The value journey: improving cost structure through performance improvement.

Healthcare financial management : journal of the Healthcare Financial Management Association·2016
Same author

Sustaining savings.

Healthcare financial management : journal of the Healthcare Financial Management Association·2009
Same journal

Highlights from the HFM blog.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

Hospitals face challenges from Medicare cost and payment trends.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

The fate of value-based care with an ACA repeal.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

Beyond the Medicare annual well visit: maximizing revenue for hospital-owned practices.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

Incorporating social determinants into population health management.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
Same journal

Health Care 2020 Part 3: Consolidation.

Healthcare financial management : journal of the Healthcare Financial Management Association·2018
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K

Reducing pharmacy costs through improved utilization.

Cinda Bates1, Barton S Richards

  • 1Trinity Regional Health System, Rock Island, Ill., USA. Cinda.Bates@unitypoint.org

Healthcare Financial Management : Journal of the Healthcare Financial Management Association
|June 26, 2013
PubMed
Summary
This summary is machine-generated.

Trinity Regional Health System reduced pharmacy expenses by using benchmarking data and a multidisciplinary team. These strategies improved cost savings and addressed quality and financial outcomes effectively.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K

Related Experiment Videos

Last Updated: Mar 6, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K

Area of Science:

  • Healthcare Management
  • Health Economics
  • Pharmacy Administration

Background:

  • Rising pharmacy expenses pose a significant challenge for healthcare systems.
  • Effective cost-containment strategies are crucial for financial sustainability in healthcare.

Purpose of the Study:

  • To outline the successful strategies implemented by Trinity Regional Health System to reduce pharmacy expenditures.
  • To demonstrate the impact of data-driven decision-making and collaborative approaches on cost reduction.

Main Methods:

  • Utilized benchmarking data to pinpoint areas for pharmacy cost savings.
  • Employed change management techniques, supported by clear data presentation, to foster adoption of new practices.
  • Established a multidisciplinary team comprising clinical and financial leaders to tackle quality, outcomes, and cost-related issues.

Main Results:

  • Identified significant opportunities for cost reduction through benchmarking.
  • Achieved successful implementation of changes via effective change management and data communication.
  • Facilitated collaborative problem-solving among clinical and financial stakeholders.

Conclusions:

  • A combination of benchmarking, change management, and multidisciplinary collaboration effectively reduces pharmacy expenses.
  • Data-driven insights and strong leadership engagement are key to achieving cost savings in healthcare settings.